Senator Aliyu Magatakarda Wamakko has urged Nigerian pharmaceutical professionals to uphold higher ethical and practice standards to improve drug safety and protect public health. Speaking in Sokoto, Wamakko emphasized the need for stronger regulatory compliance within the sector, particularly in the handling and distribution of medicines. His appeal came during a meeting with members of the Pharmaceutical Society of Nigeria. He identified weak enforcement of existing guidelines as a key challenge undermining public trust and health outcomes. Wamakko called for renewed commitment from practitioners to prioritize patient safety and professional integrity across all levels of service delivery.
Aliyu Magatakarda Wamakko's push for stricter pharmaceutical standards exposes a long-standing gap in drug oversight that affects millions of Nigerians who rely on poorly regulated medicine markets. With counterfeit and substandard drugs still circulating widely, his call could signal a shift—if enforcement follows. Sokoto State may become a test case for whether ethical practice appeals from political figures lead to measurable health gains. For now, the real measure will be whether pharmacy boards and state agencies act beyond rhetoric.
